02.11.2016 12:30:01
|
DGAP-News: SYGNIS AG
DGAP-News: SYGNIS to host Conference Call on November 09, 2016 to present nine month financial results for the period ended September 30, 2016
Madrid, Spain and Heidelberg, Germany, November 02nd, 2016 - SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) will announce financial results for the first nine month 2016 on November 09, 2016. On this occasion, the Company will host a conference call (conducted in English) at 14:00 Central European Time (CET) hosted by Pilar de la Huerta, Co-CEO and CFO of SYGNIS and Dr. Heikki Lanckriet, Co-CEO and CSO of SYGNIS to inform about the consolidated financial statements as of 30 September 2016, important developments during the reporting period and to give an update of the financial outlook.
Conference Call details:
Date and time: November 09, 2016, 14:00 CET
Interested parties can access the conference call via the following telephone numbers:
* From Germany: +49 (0) 69 7104 45598 * From Spain: +34 91 787 0777 * From the US: +1 646 843 4608 * From the UK and other countries: +44 (0) 20 3003 2666
When prompted, you will be asked to give the password "SYGNIS".
The conference call will be supplemented by a webcast presentation which can be accessed during the call.
Please dial in 5 minutes before the beginning of the event.
A conference call recording will be available in the "Investors" section of the Company's website at www.sygnis.com.
For further information, please contact:
SYGNIS AG MC Services AG Pilar de la Huerta Raimund Gabriel Co-CEO/CFO Managing Partner Phone: +34 91 192 36 50 Phone: +49 89 210228 0 Email: pdelahuerta@sygnis.com Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com SYGNIS AG is specialized in the development and the commercialization of proprietary technologies and offers a wide range of different commercial products addressing key challenges in molecular biology. With the acquisition of Expedeon Holdings, Ltd. based in Cambridge, UK, SYGNIS has added a complementary proteomic product portfolio. Resulting from this significant expansion, SYGNIS' product portfolio now covers the entire workflow of molecular biology. The products are sold through a direct sales force and several distribution partners in Europe, the US and Asia. SYGNIS AG has offices in Germany, Spain and the UK, production sites in the UK and the US as well as sales offices in Asia. The company is listed on the German Stock Exchange in Frankfurt in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).
### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward- looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of SYGNIS AG may deviate greatly from the established conclusions or implied predictions contained in such statements. SYGNIS does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason. ###
---------------------------------------------------------------------------
02.11.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English Company: SYGNIS AG Waldhofer Str. 104 69123 Heidelberg Germany Phone: +49 (0) 6221 3540 125 Fax: +49 (0) 6221 3540 127 E-mail: investors@sygnis.com Internet: www.sygnis.com ISIN: DE000A1RFM03 WKN: A1RFM0 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service ---------------------------------------------------------------------------
516677 02.11.2016
DGAP-News: SYGNIS AG / Key word(s): Miscellaneous
SYGNIS to host Conference Call on November 09, 2016 to present nine month
financial results for the period ended September 30, 2016
02.11.2016 / 12:30
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Press Release
SYGNIS to host Conference Call on November 09, 2016 to present nine month
financial results for the period ended September 30, 2016
Madrid, Spain and Heidelberg, Germany, November 02nd, 2016 - SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) will announce financial results for the first nine month 2016 on November 09, 2016. On this occasion, the Company will host a conference call (conducted in English) at 14:00 Central European Time (CET) hosted by Pilar de la Huerta, Co-CEO and CFO of SYGNIS and Dr. Heikki Lanckriet, Co-CEO and CSO of SYGNIS to inform about the consolidated financial statements as of 30 September 2016, important developments during the reporting period and to give an update of the financial outlook.
Conference Call details:
Date and time: November 09, 2016, 14:00 CET
Interested parties can access the conference call via the following telephone numbers:
* From Germany: +49 (0) 69 7104 45598 * From Spain: +34 91 787 0777 * From the US: +1 646 843 4608 * From the UK and other countries: +44 (0) 20 3003 2666
When prompted, you will be asked to give the password "SYGNIS".
The conference call will be supplemented by a webcast presentation which can be accessed during the call.
Please dial in 5 minutes before the beginning of the event.
A conference call recording will be available in the "Investors" section of the Company's website at www.sygnis.com.
For further information, please contact:
SYGNIS AG MC Services AG Pilar de la Huerta Raimund Gabriel Co-CEO/CFO Managing Partner Phone: +34 91 192 36 50 Phone: +49 89 210228 0 Email: pdelahuerta@sygnis.com Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com SYGNIS AG is specialized in the development and the commercialization of proprietary technologies and offers a wide range of different commercial products addressing key challenges in molecular biology. With the acquisition of Expedeon Holdings, Ltd. based in Cambridge, UK, SYGNIS has added a complementary proteomic product portfolio. Resulting from this significant expansion, SYGNIS' product portfolio now covers the entire workflow of molecular biology. The products are sold through a direct sales force and several distribution partners in Europe, the US and Asia. SYGNIS AG has offices in Germany, Spain and the UK, production sites in the UK and the US as well as sales offices in Asia. The company is listed on the German Stock Exchange in Frankfurt in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).
### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward- looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of SYGNIS AG may deviate greatly from the established conclusions or implied predictions contained in such statements. SYGNIS does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason. ###
---------------------------------------------------------------------------
02.11.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English Company: SYGNIS AG Waldhofer Str. 104 69123 Heidelberg Germany Phone: +49 (0) 6221 3540 125 Fax: +49 (0) 6221 3540 127 E-mail: investors@sygnis.com Internet: www.sygnis.com ISIN: DE000A1RFM03 WKN: A1RFM0 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service ---------------------------------------------------------------------------
516677 02.11.2016

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Expedeon (ex Sygnis)mehr Nachrichten
Keine Nachrichten verfügbar. |